ABSTRACT: Whereas iron−sulfur (Fe−S) cluster assembly on the wild-type scaffold protein ISCU, as catalyzed by the human cysteine desulfurase complex (NIA) 2 , exhibits a requirement for frataxin (FXN), in yeast, ISCU variant M108I has been shown to bypass the FXN requirement. Wild-type ISCU populates two interconverting conformational states: one structured and one dynamically disordered. We show here that variants ISCU(M108I) and ISCU(D39V) of human ISCU populate only the structured state. We have compared the properties of ISCU, ISCU(M108I), and ISCU(D39V), with and without FXN, in both the cysteine desulfurase step of Fe−S cluster assembly and the overall Fe−S cluster assembly reaction catalyzed by (NIA) 2 . In the cysteine desulfurase step with dithiothreitol (DTT) as the reductant, FXN was found to stimulate cysteine desulfurase activity with both the wild-type and structured variants, although the effect was less prominent with ISCU(D39V) than with the wild-type or ISCU(M108I). In overall Fe−S cluster assembly, frataxin was found to stimulate cluster assembly with both the wild-type and structured variants when the reductant was DTT; however, with the physiological reductant, reduced ferredoxin 2 (rdFDX2), FXN stimulated the reaction with wild-type ISCU but not with either ISCU(M108I) or ISCU(D39V). Nuclear magnetic resonance titration experiments revealed that wild-type ISCU, FXN, and rdFDX2 all bind to (NIA) 2 . However, when ISCU was replaced by the fully structured variant ISCU(M108I), the addition of rdFDX2 to the [NIA−ISCU(M108I)−FXN] 2 complex led to the release of FXN. Thus, the displacement of FXN by rdFDX2 explains the failure of FXN to stimulate Fe−S cluster assembly on ISCU(M108I).
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ron−sulfur (Fe−S) clusters are ancient protein prosthetic groups that are involved in numerous biological processes.
1−3 Biogenesis of Fe−S clusters is conserved in all kingdoms of life. 4−6 The Fe−S cluster biosynthesis (ISC) machinery in human mitochondria, which involves at least 18 proteins, can be divided into two major steps: cluster assembly on the scaffold protein and cluster transfer to recipient proteins. 7−9 Defects in protein components of the human mitochondrial ISC machinery have been associated with numerous diseases. 10, 11 Central to the ISC machinery is the pyridoxal 5′-phosphate (PLP)-dependent protein cysteine desulfurase, which catalyzes the conversion of cysteine to alanine and mobilizes the released sulfur for cluster assembly. 12, 13 Unlike its bacterial homologue (IscS), human cysteine desulfurase (NFS1) requires two small accessory proteins, namely, ISD11 and acyl carrier protein (ACP), for full function and stability. ISD11, also known as LYRM4, is a member of the LYRM (Leu-Tyr-Arg motif) protein family. 14, 15 ACP is well-known to function in mitochondrial fatty acid biosynthesis through reactions involving its 4′-phosphopantethiene (4′-PPT) cofactor, which is conjugated to a conserved serine residue. 16, 17 Recently, yeast Acp1 was also found to be an essential component of the cysteine desulfurase complex. 18 We demonstrated that Escherichia coli Acp substitutes for human mitochondrial ACP in the cysteine desulfurase complex produced by co-expressing human ISD11 and NFS1 in E. coli cells and determined the stoichiometry to be [NFS1] 2 :[ISD11] 2 : [Acp] 2 , 19 henceforth abbreviated as (NIA) 2 . This stoichiometry has been confirmed by two recently published X-ray structures of (NIA) 2 complexes prepared by overexpressing NFS1 and ISD11 in E. coli cells, although, curiously, the two structures exhibit quite different quaternary architecture. 20, 21 In the E. coli system, IscX has been shown to serve as the iron donor for in vitro Fe−S cluster assembly on IscU catalyzed by IscS. 22 However, IscX has no eukaryotic homologue, and the identity of the iron donor in mitochondrial Fe−S cluster biosynthesis has remained controversial. Frataxin (FXN), a protein whose defects are associated with the common neurodegenerative disease, Friedreich ataxia, 23 has been proposed as the iron donor because of its ability to bind iron and donate iron for in vitro Fe−S cluster assembly reactions. 24, 25 FXN has also been shown to enhance sulfur transfer and control entry of iron into ISCU. 26−28 However, the discovery in yeast of an Isu1 mutant that obviates the requirement for frataxin has presented a strong argument against frataxin being the primary iron donor. 29−31 In this mutant of the scaffold protein, a methionine, which is invariant in mitochondrial ISCU proteins, is substituted with isoleucine, which is the homologous residue in bacterial IscU proteins (Figure 1) . It has been shown that changing the Met residue to Ile in Saccharomyces cerevisiae Isu1 converts the yeast into a frataxin-independent organism and that changing Ile to Met in E. coli IscU turns the bacterium into a frataxin-dependent organism. 32, 33 The molecular mechanisms behind these effects have remained elusive.
In human mitochondria, assembly of a [2Fe-2S] cluster on scaffold protein ISCU involves reduced ferredoxin (rdFDX1 or rdFDX2), 35−38 which donates electrons for the reduction of S 0 generated by cysteine desulfurase. It has been shown in a yeast system (S. cerevisiae) that ferredoxin (Yah1), scaffold protein (Isu1), and frataxin (Yfh1) bind simultaneously to the cysteine desulfurase to form a large complex. 35 By contrast, in the E. coli system, the binding of bacterial frataxin (CyaY) and ferredoxin (Fdx) to the IscS−IscU complex was found to be mutually exclusive. 39, 40 CyaY has been shown to be a negative regulator of Fe−S cluster assembly in E. coli.
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Wild-type human ISCU, like its E. coli homologue IscU, 42, 43 has been found to populate two interconverting conformational states: one structured (S) and one dynamically disordered (D) . Here, we demonstrate that both ISCU(M108I) and another variant, ISCU(D39V), are fully structured. We have compared the in vitro functional properties of wild-type ISCU and these two structured variants in the cysteine desulfurase reaction and in overall Fe−S cluster assembly. Additional NMR titration studies revealed that rdFDX2 displaces FXN from the (NIA) 2 complex when the bound scaffold protein is ISCU(M108I) but not when it is wild-type ISCU. These results shed new light on the mechanism of the observed frataxin bypassing activity of ISCU(M108I). , and unlabeled FDX2 were produced and purified as described previously. 19, 38, 43 The expression plasmids for ISCU variants M108I and D39V were produced by using the Polymerase Incomplete Primer Extension (PIPE) site-directed mutagenesis method. 44 Unlabeled, uniformly 15 N-labeled, and uniformly 15 N-and 13 Clabeled samples of ISCU(M108I) and ISCU(D39V) were produced and purified as described previously for ISCU. 15 N HSQC, three-dimensional (3D) HNCA, 3D HNCO, 3D HNCACB, and 3D CBCA(CO)NH. All 3D spectra were recorded using non-uniform sampling (NUS) with a sampling rate of 36% and were processed using NESTA 47 and NMRPipe. The PINE server 48 was used for the automatic assignment of the backbone signals followed by manual refinements. The assignments of the backbone signals of ISCU(M108I) and ISCU(D39V) have been deposited in the BMRB 49 as entries 27088 and 27089, respectively.
To study the interaction between ISCU(M108I) and (NIA) 2 , a 0.3 mM sample of [U-
15 N]ISCU(M108I) was placed in a 5 mm Shigemi NMR tube, and 2D 1 H− 15 N TROSY-HSQC spectra were collected before and after titration with unlabeled (NIA) 2 .
Chemical shift perturbations (Δδ HN absolute value in parts per million) were calculated with eq 1:
where Δδ H and Δδ N are the chemical shift changes in the 1 H and 15 N dimensions, respectively. Circular Dichroism (CD) Spectroscopy. The sample buffer used in circular dichroism (CD) experiments contained 20 mM NaH 2 PO 4 and 50 mM NaCl (pH 8). The solutions were placed in 1 mm path length quartz cuvettes. The concentrations of ISCU and ISCU(M108I) were both 20 μM. Far-ultraviolet CD spectra of the samples were collected at 25°C
with an Aviv 202SF CD spectrophotometer. Isothermal Titration Calorimetry (ITC) Measurement. A Nano ITC (TA Instruments) system was used to investigate the interactions between ISCU(M108I) and (NIA) 2 . Both (NIA) 2 and ISCU(M108I) were dialyzed extensively against HNT buffer. The sample cell (169 μL) contained 0.1 mM ISCU(M108I), and the syringe (50 μL) contained 1.1 mM (NIA) 2 . Twenty aliquots of 2.5 μL of (NIA) 2 were injected into the sample cell, and the heat generated after each injection was measured. NanoAnalyse software was used in processing and fitting the ITC data.
Cysteine Desulfurase Assay and in Vitro Fe−S Cluster Assembly Reaction. The protein samples used in the cysteine desulfurase assay (three replicates) and Fe−S cluster assembly experiments (two replicates) were prepared in an anaerobic chamber (Coy Laboratory) with samples buffer-exchanged extensively prior to data collection with anaerobic buffer containing 20 mM HEPES (pH 7.6) and 150 mM NaCl (HN buffer). The reaction volumes in all the experiments were kept at 1 mL. A Shimadzu UV-1700 UV/vis spectrophotometer with a temperature control unit was used to collect the spectra, and Biochemistry Article UVProbe 2.21 software (Shimadzu) was used in collecting and analyzing the data.
The cysteine desulfurase assay reaction mixtures (300 μL in HN buffer) contained 1 μM (NIA) 2 . The reductant was 100 μM DTT; 50 μM L-cysteine was added to initiate the reaction. One or more of the following components were added to assess their effects on sulfide production: 10 μM ISCU, 10 μM FXN, and 10 μM ISCU(M108I). After anaerobic incubation at room temperature for 20 min, the reaction mixture was diluted to 800 μL, and 100 μL of 20 mM N,N-dimethyl-p-phenylenediamine in 7.2 M HCl and 100 μL of 30 mM FeCl 3 in 1.2 M HCl were added to quench the reaction and convert sulfide to methylene blue. The quenched reaction mixture was incubated for 15 min at room temperature, and then the absorbance at 670 nm was measured and used to estimate the amount of sulfide by comparison to a standard curve obtained from known concentrations of Na 2 S.
The in vitro Fe−S cluster reconstitution assays were performed as follows. Reaction mixtures (1 mL) prepared in the anaerobic chamber contained 100 μM DTT or rdFDX2 as the reductant, 0.5 μM (NIA) 2 , 25 μM ISCU, ISCU(M108I), or ISCU(D39V), and 100 μM (NH 4 ) 2 Fe(SO 4 ) 2 ; 25 μM FXN was added in reactions with FXN. L-Cysteine (final concentration of 100 μM) was added to initiate each experiment. Samples were Figure 2B ) showed evidence of two conformational states with ∼30% of the molecules in the structured S state and 70% in the disordered D state as reported previously. 43 The peaks from ISCU(M108I) were found to overlap closely with the S-state peaks from ISCU ( Figure 2C ), indicating that their structures are similar. CD spectra ( Figure 2D ) also demonstrate that ISCU(M108) adopts a structured conformation while ISCU is partially disordered.
Assignment of the NMR Spectra of ISCU(M108I) and ISCU(D39V). Because ISCU(M108I) was found to be fully structured, we decided to compare its properties with those of another ISCU variant, ISCU(D39V), known to be structured. 43 By collecting and analyzing a series of 2D and 3D NMR spectra of protein samples labeled uniformly with Figure 4A ). Many of the residues exhibiting chemical shift differences in the two variants map to the ISCU− NFS1 interface in the structure of the complex 21 ( Figure 4B ). The 58 FKTFGCGSAI 67 region includes a cysteine residue that ligates the cluster. As expected, most other perturbations map to residues near the sequence differences (residues 39 and 108).
Investigation of the Interaction between ISCU(M108I) and Cysteine Desulfurase (NIA) 2 . We used NMR spectroscopy to study the interaction between ISCU(M108I) and the cysteine desulfurase complex (NIA) 2 Figure  5A,B) . The peaks that shifted or broadened the most correspond to residues G18, G30−A34, V40−L43, K59, F61−C63, S69, L72, N90, T91, and C98 ( Figure 5C ). The (NIA) 2 binding site on ISCU(M108I) revealed by chemical shift perturbations ( Figure 5D ) agrees well with the X-ray structure of (NIAU) 2 . 21 The interaction between ISCU-(M108I) and (NIA) 2 was further confirmed by size-exclusion chromatography (SEC) and sodium dodecyl sulfate−polyacrylamide gel electrophoresis (SDS−PAGE) ( Figure 5E,F) . The SEC profile of (NIAU(M108I)) 2 was similar to that of (NIAU) 2 ( Figure 5E ). ITC was used to quantify the interaction between ISCU(M108I) and (NIA) 2 . Titration of (NIA) 2 with ISCU(M108I) resulted in an endothermic reaction that was fitted to a 1:1 binding model with a K d of 2.6 ± 0.6 μM (Figure Biochemistry Article 5G). The binding constant is similar to that of (NIA) 2 and ISCU (K d = 1.7 ± 0.4 μM).
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Effects of Frataxin on Assembly of Clusters on the Different ISCU Variants. As a first step toward understanding the effects of ISCU mutations and the presence of FXN on the reactions involved in Fe−S cluster assembly, we investigated how they influence cysteine desulfurase activity with DTT as the reductant. No sulfide was produced by (NIA) 2 upon addition of L-cysteine or DTT alone ( Figure 6A , rightmost two bars). FXN alone had little effect on the cysteine desulfurase activity of (NIA) 2 when ISCU was not present ( Figure 6A , white bars). ISCU alone had an inhibitory effect on the cysteine desulfurase activity ( Figure 6A , by comparison of the first and seventh bars). Contrary to our expectation, FXN significantly enhanced the cysteine desulfurase activity of (NIA) 2 with both wild-type ISCU and ISCU(M108I) as the scaffold protein ( Figure 6A, black and red bars) . On the other hand, ISCU(D39V) showed strong desulfurase activity in the absence We next investigated the effect of FXN on in vitro Fe−S cluster assembly with DTT as the reductant (Figures 6B and  7A) . Surprisingly, FXN showed an even stronger stimulating effect on Fe−S cluster assembly on ISCU(M108I) than on wild-type ISCU ( Figure 6B , black and red, and Figure 7A ). However, when we used rdFDX2, the likely physiologically relevant reductant in human mitochondrial Fe−S cluster biosynthesis, 35, 38 we obtained very different results. Although FXN stimulated the rate of in vitro Fe−S cluster assembly on wild-type ISCU, it had little effect on the rate of cluster assembly on either ISCU(M108I) or ISCU(D39V) (Figures 6C  and 7B ). The rate of cluster assembly on ISCU(M108) (with or without FXN) was 50% higher than on wild-type ISCU in the absence of FXN. By contrast, the rate of cluster assembly on ISCU (D38V) (with or without FXN) was approximately half of that of wild-type ISCU in the absence of FXN (Figures 6C and  7B) .
Differential Effects of ISCU Variants on the NIAU− FXN−FDX2 Complex. We followed changes in the 1 H− 15 N TROSY-HSQC spectrum of [U- 15 N]FXN upon the addition of 0.5 subunit equivalent of (NIAU) 2 or (NIAU(M108)) 2 complexes purified by SEC. In each case, the FXN peaks exhibited severe line broadening indicative of FXN binding to these complexes (panels A and B and panels D and E of Figure  8 ). Next, we added 1.0 subunit equivalent of unlabeled FDX2 to each of the solutions. In the case of (NIAU) 2 , the addition of FDX2 led to further line broadening, which is consistent with partial formation of a larger (NIAU) 2 −FXN 2 −FDX2 2 complex ( Figure 8C ). In the case of (NIAU(M108I)) 2 , however, the addition of FDX2 led to peak sharpening and the reemergence of missing peaks, which is consistent with displacement of [U-
15 N]FXN from the (NIAU(M108I)) 2 complex by FDX2 ■ DISCUSSION ISCU(M108I) was termed the "FXN bypassing mutant", 29 because it appeared to allow functioning of iron−sulfur protein biosynthesis in the absence of frataxin in yeast. We found that ISCU(M108I) is fully structured (Figure 2) . Incidentally, the authors of the recent X-ray structure of (NIAU) 2 21 chose to use the M108I variant of ISCU "in the expectation that frataxin would be dispensable as part of the core ISC complex". The fact that ISCU(M108I) is fully structured may have contributed to successful crystallization of the complex.
The D39V and D39A variants of E. coli IscU are fully structured. 52 In vivo studies of IscU(D39A) in Azotobacter vinelandii showed that this variant forms a nondissociating, noncovalent complex with the cysteine desulfurase. 53 The homologous substitution in S. cerevisiae Isu(D37A) was found to worsen the defective growth phenotype caused by deletion of the frataxin homologue (Δyfh1). 29 We decided to include ISCU(D39V) in this study as a second example of a fully structured ISCU. Although both ISCU(M108I) and ISCU-(D39V) are structured, we found significant differences in their structures as indicated by large chemical shift differences ( Figure 4 ); these differences likely account for their different results in the cysteine desulfurase and cluster assembly reactions ( Figure 7) .
We compared the functional effects of FXN on (NIA) 2 complexes containing ISCU, ISCU(M108I), and ISCU(D39V) by performing two in vitro biochemical reactions: a cysteine desulfurase assay and a cluster assembly assay. The cysteine desulfurase assay is a nonphysiological reaction that is decoupled from cluster assembly and uses the chemical reductant DTT. In this assay, the rate of sulfide production was invariably higher in the presence of FXN than in its absence. The frataxin homologue in yeast (Yfh1) was shown to stimulate binding of cysteine to Nfs1 in the cysteine desulfurase reaction by exposing substrate binding sites, and it was proposed that Isu1(M108I) mimics this effect of Yfh1. 31 By contrast, the cluster assembly assay utilizes Fe 2+ as the iron source, and sulfur production is coupled to Fe−S cluster assembly. We compared the effects of two reductants on the Fe−S cluster assembly assay: DTT and reduced ferredoxin (rdFDX2). With nonphysiological DTT as the reductant ( Figure 6B ), FXN was observed to accelerate the Fe−S cluster assembly reaction with all three ISCU variants, with the relative enhancements decreasing in the following order: ISCU-(M108I) > ISCU > ISCU(D39V). With rdFDX2 ( Figure  6C ), in the absence of FXN, the relative Fe−S cluster assembly rates decreased in the following order: ISCU(M108I) > ISCU > ISCU(D39V). However, when FXN was present, the rate of Fe−S cluster assembly on ISCU increased greatly, but the reactions with ISCU(M108I) and ISCU(D39V) remained unchanged.
Our finding that, in the absence of FXN but in the presence of reFDX2, the rate of cluster assembly on ISCU(M108I) is significantly higher than on ISCU is in line with earlier studies in yeast. 29 This higher rate of cluster assembly may explain, in part, why the ISCU(M108I) variant in yeast cells has been found to escape the requirement for FXN.
Our results suggest that the dynamic interaction of proteins on the surface of cysteine desulfurase is key to understanding the steps leading to Fe−S cluster formation on ISCU. We propose that the mechanism for the failure of FXN to stimulate Fe−S cluster assembly on ISCU(M108I) or ISCU(D39V) is the displacement of FXN by ferredoxin (FDX2). Our NMR studies showed that, whereas with ISCU, FDX2 binds to (NIAUF) 2 to form a larger complex, with the mutant ISCU(M108I), the addition of FDX2 displaces FXN ( Figure  8 ). The displacement of FXN by FDX2 from the (NIAU-(M108I)F) 2 complex is analogous to what was seen in the E. coli system, where the binding of bacterial frataxin and the binding of ferredoxin to the IscS−IscU complex were found to be mutually exclusive. 39, 40 However, the binding of FDX2 to (NIAUF) 2 is analogous to that in the yeast system in which the ferredoxin (Yah1) was shown to bind (Nfs1−Isd11−Isu1−Yfh1) and form a larger complex. 35 Both results can be explained by overlapping binding sites for frataxin and ferredoxin, but it appears that the relative binding affinities of frataxin and ferredoxin for the different cysteine desulfurases determine the consequences. With (NIAU(M108I)) 2 , FDX2 binds more tightly and FXN is displaced, leading to loss of frataxin stimulation, whereas with IscS−IscU, CyaY binds more tightly and Fdx is displaced, leading to inhibition by CyaY. 39 The complementary mutation (I108M) in E. coli IscU was found to render the cells dependent on CyaY for viability. 33 In this case, we hypothesize that IscU(I108M) may prevent IscX binding and, instead, enables the simultaneous binding of IscU(I108M), CyaY, and reduced ferredoxin to IscS.
More studies are needed to pin down the mechanism behind the stimulatory effect of FXN over free Fe 2+ in solution. In the cysteine desulfurase reaction, the binding of FXN may serve to open the binding site of the dimeric NFS1 to better allow entry of reactants (L-cysteine and DTT) and the exit of products (sulfide and L-alanine). In the more physiological cluster assembly reaction, FXN in binding to NFS1 may position its bound iron for optimal transfer to ISCU. The number of iron ions transferred in each step has not been determined definitively, although a secondary iron binding site on Isu1 from S. cerevisiae has been suggested. 54 The concentration of free Fe 2+ in the mitochondrial matrix is exceedingly low. 55 Thus, some other bound form of Fe 2+ must be the source of the iron that recharges FXN.
